{"database": "lobbying", "table": "lobbying_activities", "rows": [[1461435, "ecbe9a66-f6c3-4bae-a4df-38d1bed44354", "Q3", "TIBER CREEK GROUP", 20744, "BAY BRIDGE STRATEGIES, INC. (ON BEHALF OF BIOCRYST PHARMACEUTICALS)", 2013, "third_quarter", "DIS", "Issues related to the development of broad-spectrum antivirals. H.R. 1960/S. 1034, National Defense Authorization Act for Fiscal Year 2014.", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2013-10-21T14:11:43.533000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1461435"], "units": {}, "query_ms": 16.533131012693048, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}